Company

About

Cingulate Inc

Cingulate Inc

Kansas City, Kansas, United States

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.

Genzada Pharmaceuticals USA, Inc

Genzada Pharmaceuticals USA, Inc

517 E 30th Ave, Suite D, Hutchinson, Kansas 67502, US

For centuries, the desire to end human suffering inflicted by disease has sparked compassion, curiosity, and decades of research and drug development. It has pushed a relentless pursuit for answers, inspired bold thinking, and driven an unfaltering will to prevail in the face of daunting odds. While answers don't come easily, Genzada Pharmaceuticals is driven by hope and something more—remarkable science. We're proud to be part of a global community of physicians, scientists, chemists, clinicians, pharmaceutical experts, and like-minded pioneers working on the frontier of drug development. Together, we work to create treatments that will turn the tide against some of the deadliest forms of cancer. Our mission is rooted in an inventive mindset that fosters ground-breaking drug development. Our discoveries are the result of painstaking scientific rigor. Our novel therapeutics stem from natural compounds that boast extraordinary efficacy when precisely formulated to disrupt cancer development and progression. These discoveries may one day change patients' lives—and the world.

NeoTherma Oncology

NeoTherma Oncology

2150 n meridian ave, wichita, kansas, united states

NeoTherma Oncology is answering the world's call for more effective, more humane cancer treatment. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treament for deep, solid tumors that is expected to increase the effectiveness of current cancer treatments, while minimizing the harshest effects of chemotherapy and radiation. NeoTherma's cutting edge non-invasive technology, seamless integration into established MRI treatment suites, and clinical development strategy set us apart as industry innovators with the vision to reimagine cancer treatment. Please see our website for more information and NTO's exciting news (http://neothermaoncology.com/)!

Ronawk

Ronawk

Olathe, Kansas, United States

Ronawk's Bio Block Universe is the first expandable Bio Platform from which other applications, processes, and technologies are developed. Ronawk's Bio Block Universe accelerates time to result by eliminating the need for sub-culture in cell production which subsequently decreases contamination risks and increases cell yield. Ronawk's Bio Block Universe transforms what was once tedious to effortless by simplifying cell culture workflows through the reduction of labor, materials, and space. Ronawk's Bio Block Universe increases biological opportunities by recapitulating the native cell environment to maintain cell viability, key characteristics, and secretion of therapeutic biologics.

TVAX Biomedical

TVAX Biomedical

Lenexa, KS

TVAX Biomedical is a biotechnology company currently performing phase 2b/3 clinical trials to test a unique cancer immunotherapy as a treatment for pediatric brain cancer.